Community Academic Profiles
Profile http://med.stanford.edu/profiles/Terrence_Blaschke/ Email this profile Generate Profile PDF
Portrait

Terrence Blaschke

Academic Appointments

Contact Information

  • Academic Offices
    Personal Information
    Email Tel (650) 725-4632

Professional Overview

Administrative Appointments

  • Assistant Dean for Medical Student Advising, Stanford University School of Medicine (2006 - present)
  • Associate Dean for Medical Student Advising, Stanford University School of Medicine (2002 - 2006)

Honors and Awards

  • Oscar B. Hunter Award, American Society for Clinical Pharmacology and Therapeutics (ASCPT) (2007)
  • Henry W. Elliott Distinguished Service Award, American Society for Clinical Pharmacology and Therapeutics (ASCPT) (2006)
  • Honorary Fellowship, American College of Clinical Pharmacology (2004)
  • Rawls-Palmer Progress in Medicine Lecture and Award, American Society for Clinical Pharmacology and Therapeutics (2002)
  • Henry J. Kaiser Award for Outstanding Contributions to Medical Education, Stanford University School of Medicine (1999)

Professional Education

B.S.: University of Denver, Honors Program, Mathematics (1964)
M.D.: Columbia University, P&S, Medicine (1968)

Graduate & Fellowship Program Affiliations

Community and International Work

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Scientific Focus

Current Research Interests

My ongoing Stanford research activities involve studies on the clinical pharmacology of drugs used in HIV-infected patients.
A focus of my laboratory’s efforts in investigating drugs used in HIV-infected patients is to optimize the individual benefit/risk of pharmacotherapy of HIV or opportunistic infections by discovering and quantifying the pharmacokinetics and pharmacodynamics (PK/PD) of drugs used in such therapy; i.e., the distribution of individual-specific dose-concentration-effect relationships in the population. My laboratory has a special interest in understanding the relationships between antiviral drug exposure and virologic and toxicological responses. In the past this has lead to studies examining drug-taking behavior in these patients, since exposure is a function of both individual variability in pharmacokinetics and individual patterns of drug-taking behavior.
At the present time, my interests in HIV are in the access and quality of antiretroviral drugs for patients from less developed countries. The use of substandard drugs carries a high risk of promoting drug resistant variants of HIV, which could have widespread consequences over the long term. Another interest is drug-drug interactions between antiretroviral drugs and drugs used to treat opportunistic infections, in particular drugs used to treat tuberculosis.

Publications

Publication tag cloud

Publication Topics

View All 90

Stanford Medicine Resources:

Footer Links: